MEDICAL DEVICES · SERVICE DETAILS

Checkup for labels and instructions

(b) The control equipment type, user and applicable listing basis, review of internal and external packaging, instructions and engagement declarations, check of key content and UDI data, resulting in recommendations for changes and review of agreed versions.

The label clearance is a document checking service and does not amount to a FDA label approval or a product listing licence. Translation, rewriting, layout, research validation and regulatory submission are confirmed separately; Use or technological changes may require separate pre-market requirements.

SERVICE OVERVIEW

What does this service help with?

The applicable regulations and product basis are identified and the purpose, model, responsible party, risk and operational information are matched with the full label material. The location of the issue, the basis, the amendment, the information to be filled and the review record may be amended as agreed.

WHO MAY NEED IT

Who should consider this service?

Preparation or modification of manufacturers, brand labelers and regulatory quality teams in the United States of America for medical device labels, instructions and packagings; Prescription, non-prescription, IVD or other specialized types are subject to individual judgement.

SCOPE & APPROACH

What could be included in the label and description review?

The product is disaggregated by content review, graphic layout and formal application, and the information gaps are marked before the changes are confirmed.

01

Product and audit basis confirmation

Check the classification codes, uses, users and the basis of the licence or exemption, and identify applicable requirements and information gaps such as IVD, prescription or non-prescription.

02

Responsible parties check with basic labels

Check name models, distribution relationships for manufactured packagings, applicable quantities and identification information, and check for consistency in English, symbols and displays.

03

Audit of risk, warning and operational statements

Check information on uses, taboo alerts, operation and application of maintenance reprocessing against technical and risk information to avoid content exceeding the supporting basis.

04

Packaging, UDI interface to master data

Check the models, DIs and applicable properties in the various versions of the packaging and instructions to conform to the data records, and send the code and GUID to a separate agreement.

05

Declaration and change impact recognition

Markings that are inconsistent with the use or statement of evidence, identification of additional uses and technological changes, etc. require further regulatory evaluation.

06

List of issues and revised review

Delivery location, basis and modification, review of the client’s revisions on an agreed basis, retention of the version and unresolved issues, and definitive final confirmation of the person.

GET READY

What to prepare for the assessment

Start with a project summary and record inventory. Share complete files after authorization and confidentiality arrangements are in place.

  • All labels, internal and external packaging and complete instructions and language versions
  • Expected use of the product, users, specifications and technical information
  • Classification code and basis for application of permission, decision or exemption
  • Risk, validation and warning operations-related support information
  • Manufacturing distribution relationships, UDI and packaging data and existing records
  • Proposed changes to content, target time, data owner and version arrangements
HOW TO START

From initial review to engagement

STEP 01

Identification of product and material range

Reconciling the applicable basis, the full label and the border of the current audit and delivery.

STEP 02

Review and document gaps on a case-by-case basis

The content and scripts are checked against product information, distinguishing between problems and information to be added.

STEP 03

Basis for revision and confirmation of feedback

(b) The location of the delivery problem, the basis and the recommendation, identifying the matters to be identified by the enterprise or the technical party.

STEP 04

Review revision and handover of versions

Reviewed and revised as agreed, records handed over and relevant data or regulatory updates suggested.

The label clearance is a document checking service and does not amount to a FDA label approval or a product listing licence. Translation, rewriting, layout, research validation and regulatory submission are confirmed separately; Use or technological changes may require separate pre-market requirements.

TIMING & FEES

Timing and fees

Information reviewed:Period of application of costs: reconciliation of official rules: 2026-11-06; Commercial services and other special purpose costs are shown separately on an actual basis.

Timing and preparation

Document preparation

Delivery by type of device, listing on the basis of completeness, labelling instructions and number of language versions and revision of rotational arrangements is identified in the absence of key technical information.

FDA processing

This document consultation did not harmonize the number of days the FDA review is completed. Where new uses are involved, formal submissions or other regulatory changes are made on a separate route, the consulting clearance cannot be called FDA approval.

Fee breakdown

FDA fees

There is no corresponding FDA application fee item for this consultancy; Official fees are charged separately if otherwise registered, applied or certified before listing.

Service fees

Review of round quotations by product and label version, depth of review, verification and revision; Translation of rewriting, layout, authentication and formal submission includes a separate statement.

Other possible costs

Translating, designing printing, labelling or UDI production, technical studies and other third-party work separate columns, GUDIS and registered listing are confirmed separately.

OFFICIAL SOURCES

Official references for applicability, filing and maintenance

Reviewed November 6, 2026. Confirm scope and deadlines based on the device, actual business activities and current FDA rules.

START WITH YOUR PRODUCT

Start with complete labels, instructions and product bases.

Provides current versions, intended uses and proposed revisions, confirming audit priorities, delivery rounds and quotations.